Department of Medicine
-
February 23, 2023
2022 another strong year for Vanderbilt Transplant Center
-
February 23, 2023
Study sheds new light on hormone therapy as menopause treatment
Vanderbilt research shows that hormone replacement therapy can be safely administered depending on the method used and the patient’s age, time since menopause, and risk of cardiovascular disease. -
February 23, 2023
NIH grant supports TB research network in Brazil
The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil. -
February 23, 2023
Bastarache takes on new role for research career development
Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center. -
February 21, 2023
Diabetes drug may improve asthma
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma. -
February 16, 2023
Breast cancer genetics: new insights
Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights. -
February 16, 2023
Targeted therapy for neuroendocrine tumors
Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.